FAA/DOT’s eIPP CTOL flights validate BETA’s ALIA platform across a 275-nautical-mile VA–MD corridor and multiple airports. Backed by United Therapeutics, the program expands organ-delivery logistics use cases and could accelerate nationwide revenue opportunities as pilots scale, strengthening BETA’s long-term growth narrative.
BETA Technologies has been selected for seven eVTOL Integration Pilot Programs, enhancing its capabilities across 10 states. This significant partnership with the U.S. DOT underscores BETA's leadership in electric aviation and positions it for rapid growth and market expansion.
Beta reported $8.9 million in quarterly revenue, doubling from last year. Net loss increased to $452 million due to preferred stock issuance. Beta forecasts revenue of $29-$33 million for the full year. Partnerships and certifications signal strong market positioning in eVTOL space. Eve Air Mobility deal could generate $1 billion over 10 years.
BETA partners with Near Earth Autonomy to develop uncrewed military aircraft. Flight testing slated for H1 2026, implying multi‑year development and defense interest.
Beta Technologies raised $1 billion in its NYSE debut with strong investor interest. Stock priced at $34, closing at $36 after initial dips in trading. Revenue doubled year-over-year, but losses increased to $183 million in 2025. Company focuses on commercial aircraft certification and slow, steady stock growth. Noted investors include Amazon and General Electric, reinforcing market confidence.